These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3607117)

  • 1. Influence of naloxone on brain and behavior of a self-injurious woman.
    Sandman CA; Barron JL; Crinella FM; Donnelly JF
    Biol Psychiatry; 1987 Jul; 22(7):899-906. PubMed ID: 3607117
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of naloxone to reduce self-injurious behavior in two developmentally disabled females.
    Beckwith BE; Couk DI; Schumacher K
    Appl Res Ment Retard; 1986; 7(2):183-8. PubMed ID: 3729382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of narcotic antagonists on self-injurious behavior: a single case study.
    Bernstein GA; Hughes JR; Mitchell JE; Thompson T
    J Am Acad Child Adolesc Psychiatry; 1987 Nov; 26(6):886-9. PubMed ID: 3429408
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of naloxone on self-injurious behavior: a case study.
    Davidson PW; Kleene BM; Carroll M; Rockowitz RJ
    Appl Res Ment Retard; 1983; 4(1):1-4. PubMed ID: 6307142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone attenuates self-abusive behavior in developmentally disabled clients.
    Sandman CA; Datta PC; Barron J; Hoehler FK; Williams C; Swanson JM
    Appl Res Ment Retard; 1983; 4(1):5-11. PubMed ID: 6870234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone and self-mutilation.
    Richardson JS; Zaleski WA
    Biol Psychiatry; 1983 Jan; 18(1):99-101. PubMed ID: 6299409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone abolishes self-injuring in a mentally retarded child.
    Sandyk R
    Ann Neurol; 1985 May; 17(5):520. PubMed ID: 4004178
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoxetine treatment of self-injurious behavior in mentally retarded patients.
    Markowitz PI
    J Clin Psychopharmacol; 1990 Aug; 10(4):299-300. PubMed ID: 2286704
    [No Abstract]   [Full Text] [Related]  

  • 9. Naltrexone in treatment of self injurious behavior: a clinical study.
    Szymanski L; Kedesdy J; Sulkes S; Cutler A; Stevens-Our P
    Res Dev Disabil; 1987; 8(2):179-90. PubMed ID: 3671810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects.
    Watson SJ; Berger PA; Akil H; Mills MJ; Barchas JD
    Science; 1978 Jul; 201(4350):73-6. PubMed ID: 351804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for the administration of opiate antagonists in treating infantile autism.
    Deutsch SI
    Am J Ment Defic; 1986 May; 90(6):631-5. PubMed ID: 2872816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone decreases self-injurious behavior.
    Herman BH; Hammock MK; Arthur-Smith A; Egan J; Chatoor I; Werner A; Zelnik N
    Ann Neurol; 1987 Oct; 22(4):550-2. PubMed ID: 3481242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis, epileptiform abnormalities and clozapine.
    Munro J; Goddard N
    Br J Psychiatry; 1992 Aug; 161():283. PubMed ID: 1521133
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychopathological changes in a patient with rhythmic midtemporal discharges after antiepileptic medication.
    Müller N; Günther W; Horn B; Laakmann G; Kugler J
    Biol Psychiatry; 1988 Apr; 23(7):741-5. PubMed ID: 3370269
    [No Abstract]   [Full Text] [Related]  

  • 15. Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment.
    Knabe R; Schulz P; Richard J
    J Autism Dev Disord; 1990 Dec; 20(4):591-3. PubMed ID: 2279977
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of naloxone on auditory hallucinations.
    Orr M; Oppenheimer C
    Br Med J; 1978 Feb; 1(6111):481. PubMed ID: 626845
    [No Abstract]   [Full Text] [Related]  

  • 17. Naloxone in chronic schizophrenia.
    Volavka J; Mallya A; Baig S; Perez-Cruet J
    Science; 1977 Jun; 196(4295):1227-8. PubMed ID: 860138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sultopride, treatment of choice for psychomotor agitation in severe encephalopathy. 33 cases in a neuropediatric milieu].
    Gadisseux JF; Fournaux J; Hallet J; Ferriere G
    Acta Neurol Belg; 1982; 82(6):327-38. PubMed ID: 7164767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone and phencyclidine: interacting effects on the limbic system and behavior.
    Contreras CM; Guzman-Flores C; Dorantes ME; Ervin FR; Palmour R
    Physiol Behav; 1981 Dec; 27(6):1019-26. PubMed ID: 7199738
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose haloperidol for stereotypic self-injurious behavior in the mentally retarded.
    Mikkelsen EJ
    N Engl J Med; 1986 Aug; 315(6):398-9. PubMed ID: 3736616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.